Steven Blum
About Steven Blum
Steven Blum is the Patient Reported Outcome Assessment Asset & Indication Lead at Bristol-Myers Squibb, with extensive experience in health economics and outcomes research.
Title
Steven Blum serves as the Patient Reported Outcome Assessment Asset & Indication Lead at Bristol-Myers Squibb. In this role, he specializes in the development and implementation of clinical outcome assessments in clinical trials.
Career History
Steven Blum has a diverse background with specific expertise across several leading organizations. He served as Director of Patient Reported Outcomes at GlaxoSmithKline from 2014 to 2018. Blum also contributed as an Advisory Panel Member for the Patient-Centered Outcomes Research Institute (PCORI) from 2013 to 2017. At Forest Laboratories/Forest Research Institute, he was the Director of Health Economics for 21 years, from 1993 to 2014.
Education and Expertise
Steven Blum earned a Certificate in Health Economics and Outcomes Research from the University of Washington in 2014. He holds an MA in Economics from The New School (2013), an MBA in Finance & Accounting from Fordham Gabelli School of Business (2002), and a BBA in Management from the University of Massachusetts Amherst (1992). His academic background underpins his extensive experience in PRO/HEOR strategies, market analytics, and patient engagement.
Achievements
In 2011, Steven Blum was selected by Pharmaceutical Executive magazine as an Emerging Pharma Leader. His career is noted for substantial contributions in developing health outcome studies across various therapeutic areas, including oncology, dermatology, psychiatry, neurology, pain, cardiovascular/metabolic, infectious diseases, and respiratory.
Specializations
Steven Blum specializes in managed markets, reporting and analytics, health economics and outcomes research (HEOR), health policy, patient engagement, and clinical outcome assessments. His work has impacted both commercial and government contracting, Medicaid reimbursement, market strategy, budget impact modeling, and training.